Suppr超能文献

载5-氟尿嘧啶微球制剂对大鼠胶质瘤有效放射增敏的影响

Influence of 5-fluorouracil-loaded microsphere formulation on efficient rat glioma radiosensitization.

作者信息

Roullin Valérie-Gaëlle, Mege Martine, Lemaire Laurent, Cueyssac Jean-Pierre, Venier-Julienne Marie-Claire, Menei Philippe, Gamelin Erik, Benoit Jean-Pierre

机构信息

INSERM ERIT-M 0104, 49100 Angers, France.

出版信息

Pharm Res. 2004 Sep;21(9):1558-63. doi: 10.1023/b:pham.0000041448.22771.48.

Abstract

PURPOSE

To determine (i) the efficiency of radiosensitizing 5-FU-loaded microspheres and (ii) the impact of microparticle formulation on response to treatment.

METHODS

C6 tumor-bearing rats were stereotactically implanted with microspheres and/or allocated to: control groups (untreated) or treatment (only radiotherapy; fast-release 5-FU microspheres + radiotherapy; slow-release 5-FU microspheres + radiotherapy). The next day, fractionated radiotherapy, limited to the hemibrain, was initiated in all treated animals. The irradiation cycle included 36 Gy, given in 9 sessions for 3 consecutive weeks. Tumor development was assessed by T2-weighted MRI.

RESULTS

5-FU microspheres associated with radiotherapy caused a 47% complete remission rate (9/19) as opposed to the 8% rate (1/12) when radiotherapy alone or 0% in control animals. Drug delivery for 3 weeks produced better survival results (57%) compared to one-week sustained release (41%). MR images showed exponentially increasing tumor volumes during the first half of the radiotherapy cycle, followed by a decrease, and the disappearance of the tumor if survival exceeded 120 days.

CONCLUSIONS

5-FU controlled delivery is a promising strategy for radiosensitizing gliomas. Drug delivery system formulation is unambiguously implicated in both the response to treatment and the limitation of toxic side effects.

摘要

目的

确定(i)负载5-氟尿嘧啶(5-FU)的微球的放射增敏效率,以及(ii)微粒制剂对治疗反应的影响。

方法

对荷C6肿瘤的大鼠进行立体定向微球植入和/或分配至:对照组(未治疗)或治疗组(仅放疗;速释5-FU微球+放疗;缓释5-FU微球+放疗)。次日,对所有治疗动物开始进行限于半脑的分次放疗。照射周期包括36 Gy,连续3周分9次给予。通过T2加权磁共振成像(MRI)评估肿瘤进展。

结果

与放疗联合使用的5-FU微球导致47%的完全缓解率(9/19),而单独放疗时为8%(1/12),对照组动物为0%。与一周持续释放(41%)相比,3周的药物递送产生了更好的生存结果(57%)。MR图像显示在放疗周期的前半段肿瘤体积呈指数增加,随后减小,如果存活超过120天肿瘤消失。

结论

5-FU控释是一种有前景的胶质瘤放射增敏策略。药物递送系统制剂明确与治疗反应和毒副作用的限制有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验